CFO
MEDP icon

Callan Family Office’s Medpace MEDP Stock Holding History

Callan Family Office’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
475
+1
+0.2% +$462 ﹤0.01% 1062
2026
Q1 		$228K Sell
474
-107
-18% -$54.8K 0.01% 1020
2025
Q4 		$326K Buy
+581
New +$330K 0.01% 902

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Callan Family Office's MEDP Position: Q2 2026 in Review

Callan Family Office increased its Medpace (MEDP) stake by 0.21% in Q2 2026, buying an estimated $462 and bringing the position to 475 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Callan Family Office first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $326K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Callan Family Office held 475 shares of Medpace worth $252K as of Q2 2026.
  • Callan Family Office bought 1 Medpace share in Q2 2026, an estimated $462.
  • Medpace made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1062 holding.
  • Callan Family Office first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Callan Family Office's Medpace position peaked at $326K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.